Etsuro Hatano

14.7k total citations
402 papers, 8.6k citations indexed

About

Etsuro Hatano is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Etsuro Hatano has authored 402 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Surgery, 193 papers in Hepatology and 142 papers in Oncology. Recurrent topics in Etsuro Hatano's work include Hepatocellular Carcinoma Treatment and Prognosis (122 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (107 papers) and Pancreatic and Hepatic Oncology Research (69 papers). Etsuro Hatano is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (122 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (107 papers) and Pancreatic and Hepatic Oncology Research (69 papers). Etsuro Hatano collaborates with scholars based in Japan, United States and Egypt. Etsuro Hatano's co-authors include Shinji Üemoto, Kojiro Taura, Iwao Ikai, Satoru Seo, David A. Brenner, Kentaro Yasuchika, Toshimi Kaido, Yasuyuki Shimahara, Keiko Iwaisako and Takashi Nitta and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Etsuro Hatano

360 papers receiving 8.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Etsuro Hatano Japan	47	3.6k	3.3k	2.4k	2.2k	1.8k	402	8.6k
Christine Sempoux Belgium	52	2.7k 0.8×	4.4k 1.3×	2.6k 1.1×	2.8k 1.3×	1.8k 1.0×	314	9.9k
Joanne Verheij Netherlands	51	2.0k 0.6×	3.8k 1.2×	1.9k 0.8×	2.8k 1.3×	1.9k 1.1×	308	9.3k
Isao Sakaida Japan	50	3.8k 1.1×	2.6k 0.8×	1.5k 0.6×	3.6k 1.7×	2.6k 1.5×	394	10.0k
Laura Rubbia‐Brandt Switzerland	53	5.9k 1.6×	2.9k 0.9×	3.1k 1.3×	4.1k 1.9×	1.4k 0.8×	210	10.3k
Hiroshi Hasegawa Japan	42	4.7k 1.3×	4.0k 1.2×	2.1k 0.9×	2.6k 1.2×	679 0.4×	431	9.3k
Akinobu Taketomi Japan	60	6.2k 1.7×	5.6k 1.7×	3.1k 1.3×	3.5k 1.6×	2.4k 1.3×	634	13.1k
Hiromitsu Saisho Japan	53	3.3k 0.9×	2.5k 0.8×	3.1k 1.3×	2.9k 1.4×	2.1k 1.2×	260	9.3k
Kazuhide Yamamoto Japan	48	2.5k 0.7×	2.8k 0.9×	1.7k 0.7×	2.6k 1.2×	1.3k 0.7×	359	8.2k
Kojiro Taura Japan	39	3.1k 0.9×	2.1k 0.6×	1.3k 0.5×	2.5k 1.2×	1.1k 0.6×	221	6.3k
James G. Kench Australia	50	3.7k 1.0×	2.5k 0.8×	2.5k 1.0×	6.4k 3.0×	2.6k 1.5×	168	11.9k

Countries citing papers authored by Etsuro Hatano

Since Specialization

Citations

This map shows the geographic impact of Etsuro Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuro Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuro Hatano more than expected).

Fields of papers citing papers by Etsuro Hatano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuro Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuro Hatano. The network helps show where Etsuro Hatano may publish in the future.

Co-authorship network of co-authors of Etsuro Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuro Hatano. A scholar is included among the top collaborators of Etsuro Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuro Hatano. Etsuro Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anazawa, Takayuki, Kazuyuki Nagai, Yosuke Kasai, et al.. (2025). Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study. Annals of Surgical Oncology. 32(5). 3603–3613. 1 indexed citations

Seo, Satoru, et al.. (2024). Real-time navigation surgery for T2 gallbladder cancer using projection mapping with indocyanine green fluorescence. Surgical Oncology. 56. 102115–102115.

Nagai, Kazuyuki, Takayuki Anazawa, Yosuke Kasai, et al.. (2024). Optimizing terminology for pancreatectomy: Introducing a new notation system. Journal of Hepato-Biliary-Pancreatic Sciences. 31(10). 691–696. 1 indexed citations

Aoki, Hikaru, Takashi Ito, Masaaki Hirata, et al.. (2024). Adverse effects of graft congestion and ameliorative effects of hepatocyte growth factor after liver transplantation in rats. Liver Transplantation. 31(1). 11–23.

Nanno, Yoshihide, Hirochika Toyama, Kazuyuki Nagai, et al.. (2024). Endoscopic ultrasound‐guided tissue acquisition allows a reliable proliferation assessment of small (≤20 mm) pancreatic neuroendocrine tumors. Annals of Gastroenterological Surgery. 9(2). 339–346.

Itatani, Yoshiro, Kenji Kawada, Rei Mizuno, et al.. (2023). Downregulation of osteoprotegerin in colorectal cancer cells promotes liver metastasis via activating tumor-associated macrophage. Scientific Reports. 13(1). 22217–22217.

Yao, Siyuan, et al.. (2023). Occult bacteremia in living donor liver transplantation: a prospective observational study of recipients and donors. Surgery Today. 54(6). 596–605.

Nakamura, Takeharu, Yoshihiro Nishikawa, Masahiro Shiokawa, et al.. (2023). ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway. The Journal of Pathology. 261(1). 28–42. 10 indexed citations

Nakamura, Ikuo, Etsuro Hatano, Hideo Baba, et al.. (2023). Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer. Annals of Gastroenterological Surgery. 7(6). 1009–1020. 6 indexed citations

10.

Okamoto, Tatsuya, Hideaki Okajima, Eri Ogawa, et al.. (2023). The protective association of HLA‐C*12:02 and HLA‐DQB1*06:01 with severe acute hepatitis of unknown origin in the Japanese population. HLA. 103(1). e15215–e15215. 1 indexed citations

11.

Fukumitsu, Ken, Takamichi Ishii, Satoshi Ogiso, et al.. (2023). Impact of patient-specific three-dimensional printed liver models on hepatic surgery safety: a pilot study. HPB. 25(9). 1083–1092. 5 indexed citations

12.

Ito, Takashi, Satoshi Ogiso, Masanori Nakamura, et al.. (2023). Fluid analysis unveils hepatic venous outflow obstruction and its negative impact on posttransplant graft regeneration. Liver Transplantation. 29(6). 658–662. 1 indexed citations

13.

Yao, Siyuan, Kojiro Taura, Tomoaki Yoh, et al.. (2022). Nonsuperiority of technetium-99m-galactosyl human serum albumin scintigraphy over conventional volumetry for assessing the future liver remnant in patients undergoing hepatectomy after portal vein embolization. Surgery. 173(2). 435–441. 1 indexed citations

14.

Hata, Koichiro, Takahiro Nishio, Shoichi Kageyama, et al.. (2022). En bloc excision of giant polycystic liver with hepatic cava and its auto‐transplant caval reconstruction as a safe surgical procedure for liver transplantation. Journal of Hepato-Biliary-Pancreatic Sciences. 29(11). e104–e107. 1 indexed citations

15.

Kudo, Masatoshi, Kazuomi Ueshima, Yasutaka Chiba, et al.. (2019). Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial. Liver Cancer. 8(6). 505–519. 12 indexed citations

16.

Yoh, Tomoaki, Etsuro Hatano, Yosuke Kasai, et al.. (2018). Serum Nardilysin, a Surrogate Marker for Epithelial–Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection. Clinical Cancer Research. 25(2). 619–628. 10 indexed citations

17.

Nakamura, Ikuo, Yuji Iimuro, Seikan Hai, et al.. (2018). Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. European Surgical Research. 59(1-2). 12–22. 10 indexed citations

18.

Nishio, Takahiro, Kojiro Taura, Satoru Seo, et al.. (2017). Impact of statin use on the prognosis of patients with hepatocellular carcinoma undergoing liver resection: a subgroup analysis of patients without chronic hepatitis viral infection. Surgery. 163(2). 264–269. 17 indexed citations

19.

Kawai, Takayuki, Kentaro Yasuchika, Satoru Seo, et al.. (2016). Identification of Keratin 19–Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using 18F-Fluorodeoxyglucose Positron Emission Tomography. Clinical Cancer Research. 23(6). 1450–1460. 24 indexed citations

20.

Kawai, Takayuki, Kentaro Yasuchika, Takamichi Ishii, et al.. (2015). Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma. Clinical Cancer Research. 21(13). 3081–3091. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact